EMJ Oncology 10 [Supplement 4] . 2022

In this issue

Expert discussion on the evolving role of immunotherapy in extensive-stage small cell lung cancer (ES-SCLC) from symposium sessions at the virtual 2020 International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer are reviewed in this article. Masahiro Tsuboi, National Cancer Centre Hospital East, Tokyo, Japan, chaired and opened the session by exploring the role of immuno-oncology in the management of unresectable Stage III non-small cell lung cancer (NSCLC).

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.